IntroDuctIon
Development of the protocol A crucial but often underappreciated step in the development of vertebrates is the early patterning that occurs during and after gastrulation. These patterning events set up the anterior-posterior (A-P) and dorsal-ventral axes of the embryo. A-P patterning of the endoderm germ layer establishes the foregut (anterior) and midand hindgut (posterior) domains. The midgut and hindgut give rise to the small and large intestines 1 . Studies using several model organisms have shown that the fibroblast growth factor (FGF) and WNT signaling pathways promote posterior patterning and specification of the hindgut endoderm [2] [3] [4] . We hypothesized that the ability of FGF and/or WNT signaling to promote posterior endoderm patterning could be exploited to generate posterior mid-and hindgut lineages from hPSCs. In support of this, we recently published a method that demonstrates that high levels of FGF4 and WNT3A act in synergy to pattern hPSC-derived definitive endoderm (DE) into mid-and hindgut endoderm and promote a gut tube-like morphogenesis, resulting in the formation of 3D mid-and hindgut-like spheroids 5 . We then used a culture system that promotes the expansion of adult intestinal stem cells 6 to expand mid-and hindgut spheroids into 3D human intestinal tissue in culture.
We have shown that the formation of human intestinal tissue from PSCs occurs via a process that very closely mimics embryonic intestine development, giving rise to an intestinal epithelium containing absorptive enterocytes as well as the major secretory lineages (including Paneth cells, goblet cells and enteroendocrine cells). The human intestinal tissue is functional as it can secrete mucins into luminal structures, and it can absorb fluorescently labeled dipeptides, suggesting a functional dipeptide transport system 7, 8 . Intestinal tissues contain villus-like structures with microscopic brush borders as well as cryptlike structures that express intestinal stem cell markers. Finally, we have demonstrated that this is a genetically tractable system that allows for both genetic gain-and loss-of-function studies.
Experimental design
Generation of human intestinal tissue from hPSCs takes approximately 1 month: 3 d of exposure to activin A for DE induction, 4 d of exposure to FGF4 and WNT3A to generate mid-and hindgut spheroids and 14-28 d to allow spheroids to expand into intestinal tissue. During each of these steps, genetic manipulation and addition or removal of growth factors and/or chemical agonists and antagonists can be used to achieve different experimental outcomes. At each step, the appropriate controls should be included: during DE induction, a control excluding activin A is included to monitor the efficiency of DE differentiation; during the mid-and hindgut patterning step, a control excluding FGF4 and WNT3a is used to monitor both CDX2 induction and 3D spheroid generation.
Applications of the method
We believe that this culture system will be useful in a wide variety of applications, including functional studies of human intestine development, maturation and function; studies to understand factors controlling intestinal epithelial proliferation, differentiation and renewal; high-throughput analysis of drug transport and uptake studies; and infectious disease studies. In addition, using patient-specific induced pluripotent stem cells (iPSCs) will allow in vitro disease modeling to study the etiology and molecular mechanisms of disease processes. Finally, we think that this system may be a starting point for tissue replacement therapies either by direct engraftment into diseased bowel or by using bioengineering approaches to generate intestinal segments in vitro.
Comparison with other methods
Several groups have demonstrated that mouse embryonic stem cells (ESCs) and iPSCs have the capability to generate cells that express intestinal markers [9] [10] [11] [12] . However, these methods involve the spontaneous differentiation of pluripotent stem cells into embryoid bodies, which contain many cell types derived from all three primary germ layers 13 . More recently, it has been shown that endoderm and intestinal generation can be enhanced in embryoid bodies by using a two-step differentiation protocol 14 . Our differentiation method represents a major advance over previous protocols for several reasons: (i) This is the first demonstration of differentiation of hPSCs into intestinal tissue.
(ii) The
Here we describe a protocol for generating 3D human intestinal tissues (called organoids) in vitro from human pluripotent stem cells (hpscs). to generate intestinal organoids, pluripotent stem cells are first differentiated into FoXa2 + soX17 + endoderm by treating the cells with activin a for 3 d. after endoderm induction, the pluripotent stem cells are patterned into cDX2 + mid-and hindgut tissue using FGF4 and Wnt3a. During this patterning step, 3D mid-or hindgut spheroids bud from the monolayer epithelium attached to the tissue culture dish. the 3D spheroids are further cultured in Matrigel along with prointestinal growth factors, and they proliferate and expand over 1-3 months to give rise to intestinal tissue, complete with intestinal mesenchyme and epithelium comprising all of the major intestinal cell types. to date, this is the only method for efficiently directing the differentiation of hpscs into 3D human intestinal tissue in vitro.
protocol directs differentiation of PSCs through stages that mimic embryonic intestinal development and is highly efficient, resulting in organoids containing an epithelium (of which more than 90% of the epithelium in all organoids expresses CDX2). (iii) 3D growth results in intestinal tissue with both secretory and absorptive function. (iv) Organoids contain all of the intestinal epithelial cell types and similar architecture with villus-and crypt-like structures. (v) Organoids contain a stratified mesenchyme and express markers of smooth muscle and intestinal subepithelial myofibroblast cells.
The method described herein does not rely on the inherent ability of ESCs to spontaneously differentiate into all tissue lineages. Furthermore, to our knowledge, this is the first protocol to describe a defined set of growth factors that are required at each stage of differentiation to mimic embryonic development in vitro.
Despite offering such great potential, this system is not without its limitations. For example, the intestinal organoids lack several components of the intestine in vivo, such as the enteric nervous system as well as the vascular, lymphatic and immune systems. Additionally, whereas all of the major epithelial cell types are generated in proportions similar to those found in vivo, and there is evidence of crypt-like domains housing stem cells, the 3D architecture is not as regular as that seen in vivo and the villus-like structures are variable from one organoid to the next.
Regardless of these drawbacks, we believe that this system has extraordinary experimental utility for understanding and modeling human intestinal development, homeostasis and disease. Moreover, this system provides a viable starting point for future efforts at bioengineering human intestine. 15 . Briefly, hPSCs are cultured on hESC-qualified, Matrigel-coated Nunclon delta surface plates (six wells) in a 5% CO 2 incubator at 37 °C. Cells are passaged onto new plates every 4-5 d using Dispase (1 mg ml − 1 ; National Stem Cell Bank Protocols, http://www.wicell.org/). Dispase Resuspend Dispase in advanced DMEM-F12 to a final concentration of 1 mg ml − 1 . Filter-sterilize using a Millipore filter sterilization tube, make 10-ml aliquots and store aliquots at − 20 °C for up to 6 months. Aliquoting Matrigel for hPSC culture Thaw hPSC-qualified Matrigel on ice or overnight at 4 °C. Chill sterile microcentrifuge tubes in a microcentrifuge rack at 4 °C for 1 h prior to aliquoting Matrigel. Aliquot Matrigel into cold microcentrifuge tubes and store at − 80 °C for up to 6 months.  crItIcal Matrigel will solidify at room temperature (20-25 °C), so it is important to work quickly and keep Matrigel cold throughout the aliquoting process. Matrigel-coating plates for hPSC culture Coat 6-or 24-well Nunclon delta surface plates with hESC-qualified Matrigel as described by the manufacturer.
MaterIals

REAGENTS
Briefly, thaw Matrigel on ice (final dilution is determined by the manufacturer and is lot-dependent) and resuspend in cold advanced DMEM-F12 medium. Add enough cold medium plus Matrigel to the tissue culture plate so that the entire surface is covered (1 ml per well for a 6-well and 0.5 ml per well for a 24-well plate). Incubate plates at room temperature for at least 1 h before plating hPSCs, but plates can be stored at 4 °C for up to 1 week.  crItIcal Matrigel will solidify at room temperature, so it is important to add Matrigel to cold medium before coating plates. Matrigel for intestine culture (intestinal Matrigel) Thaw the bottle of Matrigel on ice or at 4 °C. Once the Matrigel has thawed, add B27 supplement (final concentration 1×), Rspondin1 (final concentration 500 ng ml − 1 ), noggin (final concentration 100 ng ml − 1 ) and EGF (final concentration 100 ng ml − 1 ). Mix well by pipetting. While keeping Matrigel cold at all times, make 50-µl aliquots into 1.5-ml microcentrifuge tubes and store them at − 80 °C for up to 6 months.  crItIcal We have found that adding growth factors to Matrigel is not crucial, but it does increase the efficiency of spheroid outgrowth. Growth factor reconstitution Reconstitute growth factors in 1× PBS to the following final concentrations: activin A 100 ng µl After reconstitution, growth factors can be stored at 4 °C for up to 1 week. For long-term storage (up to 6 months), make aliquots of growth factors and store them at − 80 °C. Thawed aliquots can be stored at 4 °C for up to 1 week. We do not refreeze growth factors once they have been thawed. Day 1 endoderm differentiation medium Combine RPMI 1640, l-glutamine (final concentration 2 mM), penicillin-streptomycin (final concentration penicillin 100 U ml − 1 ; streptomycin 100 µg ml − 1 ) and activin A (final concentration 100 ng ml − 1 ). Endoderm differentiation medium is best if made freshly each day, but it can be stored at 4 °C for 1-3 d.  crItIcal No serum is used in medium on day 1.
Day 2 endoderm differentiation medium Combine RPMI 1640, 0.2% (vol/vol) dFBS, l-glutamine (final concentration 2 mM), penicillinstreptomycin (final concentration penicillin 100 U ml − 1 ; streptomycin 100 µg ml − 1 ) and activin A (final concentration 100 ng ml − 1 ). Endoderm differentiation medium is best if freshly made each day, but it can be stored at 4 °C for 1-3 d. Day 3 endoderm differentiation medium Combine RPMI 1640, 2% (vol/vol) dFBS, l-glutamine (final concentration 2 mM), penicillinstreptomycin (final concentration penicillin 100 U ml − 1 ; streptomycin 100 µg ml − 1 ) and activin A (final concentration 100 ng ml − 1 ). Endoderm differentiation medium is best if freshly made each day, but it can be stored at 4 °C for 1-3 d. Mid-and hindgut differentiation medium Combine RPMI 1640, 2% (vol/vol) dFBS, l-glutamine (final concentration 2 mM), penicillinstreptomycin (final concentration penicillin 100 U ml ) and WNT3A (final concentration 500 ng ml − 1 ). Freshly prepare mid-and hindgut differentiation medium on the first day of induction and store it at 4 °C for up to 4 d. Intestine growth medium Combine advanced DMEM-F12, B27 supplement (1× final dilution = 2 ml per 50 ml of medium), l-glutamine (final concentration 2 mM), penicillin-streptomycin (final concentration penicillin 100 U ml − 1 ; streptomycin 100 µg ml ) and EGF (final concentration 100 ng ml − 1 ). Intestine growth medium is best if freshly made, but it can be stored at 4 °C for up to 1 week. PBST PBST contains PBS and 0.5% (vol/vol) Triton X-100. PBST can be made ahead of time and stored at room temperature for up to 6 months. Immunostaining blocking buffer Add 10% (vol/vol) donkey serum to PBST (for example, 100 µl donkey serum to 900 µl PBST). Make freshly before each use and keep on ice. proceDure passaging hpscs • tIMInG 2 h 1| At least 1 h before passaging hPSCs, coat a 24-well Nunclon delta tissue culture plate with Matrigel as described in REAGENT SETUP.
2|
Start with a six-well dish of cells that are approximately 85-90% confluent and that are largely differentiation free (Fig. 1) . If spontaneous differentiation is visible, this tissue can be manually removed using a tungsten needle or pulled by a Pasteur pipette. Aspirate mTeSR1 from the six-well dish of hPSCs.  crItIcal step The starting density of the six-well dish is crucial for obtaining optimal results in the following steps.
3| Cover each well with 1 ml of Dispase and place it into the incubator at 37 °C until the edges of colonies start to lift.  crItIcal step Dispase treatment must be optimized for each lot, as the enzymatic activity varies from lot to lot.
4|
Wash wells three times with warm advanced DMEM-F12.
5|
After the third wash, place 3 ml of warm mTesR1 into each well and dislodge colonies from the plate using a sterile cell scraper.
6|
Withdraw medium containing hPSC colonies from the dish using a 10-ml serological pipette. Triturate colonies by forcefully expelling medium and hPSCs from the serological pipette back into the tissue culture dish so that the colonies will be broken into smaller pieces. Repeat this 3-5 times until colonies are broken into the desired size.  crItIcal step We have determined that it is optimal to break colonies into pieces that are 1-2 mm in diameter before plating onto 24-well dishes.
7| Passage triturated colonies from the 6-well dish into a Matrigel-coated 24-well dish at a 1:6 ratio. That is, each well from the 6-well dish, containing 3 ml of medium + hPSCs will be plated into six wells of a 24-well dish, with each well receiving 0.5 ml of medium + hPSCs. Optimally, 5,000 triturated hPSC colony pieces are aliquoted per well (Fig. 1c-e) .  crItIcal step Optionally, sterile, plastic cover slips can be placed in the 24-well dish before Matrigel coating so that cells can be removed for subsequent immunostaining and analysis with confocal microscopy. The use of plastic, not glass, cover slips is crucial to hPSC attachment and growth.
8|
Ensure that hPSC colonies are evenly distributed in the wells by gently tapping on the side of the 24-well dish five to ten times. Confirm even distribution under a stereomicroscope. Place the 24-well dish in the 37 °C incubator overnight.
Growth of hpscs to 85-90% confluence for differentiation • tIMInG 3-4 d 9|
The next day, observe the 24-well dish with hPSCs under a stereomicroscope. Do not be alarmed if much of the material passaged the day before appears dead and is floating in the medium.
10|
Aspirate the medium and any floating debris from each well with a sterile Pasteur pipette. 11| Add 0.5 ml of fresh, prewarmed mTeSR1 to each well. Upon further observation, the remaining hPSC colonies of a similar size should be uniformly distributed throughout the well (Fig. 1c-e) .  crItIcal step Uniform distribution of hPSCs is critical for obtaining an approximately 85-90% confluent layer of hPSC colonies with minimal spontaneous differentiation (Fig. 1f-h) . Plating cells too densely will lead to premature spontaneous differentiation (Fig. 1f) . Similarly, if starting densities are too sparse, adequate confluency may never be reached. ? trouBlesHootInG 12| Feed the 24-well dish with 0.5 ml per well of fresh mTesR1 and observe the colony density daily. hPSC colonies will reach approximately 85-90% confluency for differentiation within 2-4 d.  crItIcal step If colony density of the 24-well plate is too dense or too sparse after 2-4 d, discard the plate and start over, as differentiation will be inefficient and yield poor results (Figs. 1f,i and 2) . If colonies are too dense at the start of endoderm differentiation, we observe regions that appear undifferentiated at the end of the DE stage (Fig. 1i) . 
Differentiating hpscs into human De
14|
To each well, add 0.5 ml of prewarmed day 1 endoderm differentiation medium and place the plate back in the incubator.  crItIcal step After removing mTesR1, it is not necessary to wash cells with prewarmed RPMI 1640 medium prior to starting endoderm differentiation. Steps 18-20
Steps 22-28
Step 29 15| After 24 h, aspirate day 1 endoderm differentiation medium and replace with 0.5 ml per well of prewarmed day 2 endoderm differentiation medium.  crItIcal step It is normal to observe large amounts of floating cell debris each day during the endoderm differentiation protocol.
16|
After 24 h, aspirate day 2 endoderm differentiation medium and replace with 0.5 ml per well of prewarmed day 3 endoderm differentiation medium.
17|
After 24 h, aspirate day 3 endoderm differentiation medium and wash cells once with day 3 endoderm differentiation medium without activin A. Optionally, if hPSCs were plated on plastic cover slips (see Step 7) , gently remove the plastic cover slips and associated DE with forceps to perform immunostaining for FOXA2 and SOX17; this will allow you to determine the efficiency of DE differentiation as described in Box 1.  crItIcal step Upon observing cells under a microscope, a flat, confluent sheet of DE should be present (Fig. 1j) . This tissue should contain very little 3D structure.  crItIcal step The endoderm should be confluent after differentiation. If cells are too dense, mid-and hindgut spheroids will not form (Fig. 2g,j) . If cells are too sparse, mid-and hindgut spheroids may form, but they will do so with a lower efficiency (Fig. 2i,l ) and they will not efficiently form intestinal organoids. ? trouBlesHootInG
Differentiating human De into human mid-and hindgut • tIMInG 3-4 d 18|
Aspirate media from 24-well plate of DE and replace with 0.5 ml per well of prewarmed mid-and hindgut differentiation medium. Replace with fresh mid-and hindgut differentiation medium every 24 h for up to 96 h (4 d).  crItIcal step Before changing the medium each day, observe the tissue under a stereomicroscope. After ~48 h of exposure to mid-and hindgut differentiation medium, 3D structures will start to become visible (Fig. 2d-f ). In extremely robust cultures under optimal conditions, it is possible to see free-floating mid-and hindgut spheroids that have detached from the dish after 48 h. If free-floating spheroids are present, proceed to Step 19. If no spheroids are present, repeat this step.
19|
Collect spheroids from every well under a stereomicroscope using a 200-µl barrier pipette tip and pool approximately 50 spheroids into a 1.5-ml microcentrifuge tube. Proceed to
Step 22 with spheroids.  crItIcal step Pooling approximately 50 spheroids per 1.5-ml microcentrifuge tube will reduce the time spent on subsequent culturing steps. ? trouBlesHootInG 20| After collecting spheroids from every well, aspirate the remaining medium and replace it with fresh medium as described in
Step 18. 
27|
After each well of the four-well dish contains a bead of Matrigel + spheroids, place the dish into the 37 °C incubator for 10 min to allow the Matrigel to solidify.
28| Gently pipette 0.5 ml of intestine growth medium into each well, ensuring that Matrigel/spheroid bead is covered.
29|
Replace intestine growth medium every 4 d, or when the phenol red in the medium turns yellow.
splitting human intestinal tissue • tIMInG 2-3 h to split tissue, 14 d to grow tissue 30|
After approximately 14 d, reduce the density of tissue in each well by splitting the organoids into fresh Matrigel (Fig. 3d,e) . To do this, first thaw one tube of intestinal Matrigel on ice for every 10-12 organoids that successfully grew during the first 14 d. ? trouBlesHootInG 31| By using a sterile scalpel or scissors, trim the tip of a 200-µl pipette to increase the bore size of the pipette such that organoids can pass through the tip without sustaining damage (2-3 mm in diameter).
32|
With the cut 200-µl pipette tip, dislodge the Matrigel bead containing organoids from each well.
33|
Using this tip, vigorously pipette the Matrigel up and down 3-5 times to free the organoids from the Matrigel.
34|
Pool all the Matrigel + organoids + medium from each well into a sterile Petri dish containing 10 ml of warm advanced DMEM-F12. By using a sterile tungsten needle or sterile fine forceps, dislodge any large pieces of Matrigel that are still adherent to the organoids. 
39|
Under a stereomicroscope, manually cut the organoids into halves using a sterile scalpel. The use of a pair of sterile fine forceps or a tungsten needle to hold organoids in place while cutting will greatly enhance the ease of this step. (Fig. 3i shows the cutting plane of a 28-d organoid.) 
41|
Cut organoid halves will grow and expand (Fig. 3j) . Repeat Steps 37-40 every 10-14 d as necessary. We have repeated this expansion for up to 140 d.
? trouBlesHootInG Troubleshooting advice can be found in table 1.
• . During the 4-d mid-and hindgut induction protocol, morphogenetic tissue movements in the tissue culture dish will give rise to 3D structures, including epithelial tubes and spheroids. 3D structure is typically first observed at the end of the second day of induction (after 48 h) and appears mostly as thickenings of the adherent epithelium. Within 2-3 d, spherical structures will begin to delaminate from the adherent epithelium, and morphogenesis is complete by the end of 4 d, at which time spheroids will contain a CDX2 + E-cadherin-positive epithelial layer surrounded by a CDX2 + E-cadherin-negative mesenchymal layer that is strikingly similar to mouse mid-and hindgut development at embryonic day (E) 8.5 (ref. 5). On the third and fourth day of the mid-and hindgut induction protocol, more than 20 spheroids are generated per well (ranging from 20 to 42). The robustness of spheroid generation is dependent on the efficiency of endoderm differentiation and the density/confluency of the endoderm at the end of the 3-d endoderm induction step (Figs. 1 and 2) .
By using in vitro culture conditions that support the growth and expansion of adult mouse intestinal stem cells 6 , human hindgut spheroids proceed through a series of developmental events that mimics in vivo intestinal development 5 . During the first 14 d in culture, spheroids expand into organoids, giving rise to a pseudostratified epithelium that coexpresses the fetal intestinal transcription factors CDX2, SOX9 and KLF5. Over the next 14 d, the pseudostratified intestinal epithelium 6, 16 . After the first 28 d in culture, organoids can be passaged by manually cutting them in half with a scalpel. After the organoids are cut in half and re-embedded into Matrigel, they will continue to grow and tissue will undergo an approximate doubling every 10-14 d. We have successfully passaged organoids for up to 8 passages, spanning approximately 140 d, stopping only for an experimental endpoint. It is likely that human organoids will continue to grow and expand much longer than this. It is possible that there is a less time-consuming method by which to split and expand human organoids; however, to date we have only performed manual passaging. coMpetInG FInancIal Interests The authors declare competing financial interests (see the HTML version of this article for details).
